lupus News
Most Popular lupus Story
HGS' lupus drug Benlysta fails secondary trial goal
Human Genome Sciences (NASDAQ: HGSI) has released an updated look at its experimental lupus drug, noting that the closely watched Benlysta failed to achieve a secondary endpoint on a statistically Read more...
Latest Headlines
- December 6, 2010
- November 16, 2010
- November 15, 2010
- November 10, 2010
- April 20, 2010
- November 19, 2009
- August 26, 2009
- July 20, 2009
- April 29, 2008
- January 22, 2008
- October 18, 2007
- September 19, 2007
- September 10, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
